Posted: February 21, 2017
In 2011, the FDA issued a warning that not only documented the dangers of vaginal mesh for the treatment of pelvic organ prolapse (POP), but suggested there was no evidence the surgery was any more effective than non-mesh procedures. In 2016, the FDA reclassified vaginal mesh as a “high-risk”...
